Compare TLX & PVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLX | PVH |
|---|---|---|
| Founded | 2015 | 1881 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.7B |
| IPO Year | N/A | N/A |
| Metric | TLX | PVH |
|---|---|---|
| Price | $9.02 | $75.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 15 |
| Target Price | $21.00 | ★ $93.43 |
| AVG Volume (30 Days) | 115.0K | ★ 952.2K |
| Earning Date | 01-01-0001 | 12-03-2025 |
| Dividend Yield | N/A | ★ 0.20% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.04 | ★ 6.69 |
| Revenue | $664,225,558.00 | ★ $8,816,700,000.00 |
| Revenue This Year | N/A | $3.63 |
| Revenue Next Year | N/A | $2.20 |
| P/E Ratio | $284.97 | ★ $11.25 |
| Revenue Growth | ★ 55.35 | 0.52 |
| 52 Week Low | $8.76 | $59.28 |
| 52 Week High | $30.36 | $111.71 |
| Indicator | TLX | PVH |
|---|---|---|
| Relative Strength Index (RSI) | 38.74 | 43.60 |
| Support Level | $9.37 | $74.21 |
| Resistance Level | $10.03 | $88.61 |
| Average True Range (ATR) | 0.25 | 3.26 |
| MACD | -0.00 | -0.54 |
| Stochastic Oscillator | 7.65 | 8.37 |
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
PVH designs and markets branded apparel in more than 40 countries. Its key fashion categories include men's dress shirts, ties, sportswear, underwear, and jeans. Its two designer brands, Calvin Klein and Tommy Hilfiger, now generate practically all its revenue after its recent disposition of most of its smaller brands. PVH operates e-commerce sites, about 1,400 stores, and about 1,500 shop-in-shops and concessions. The firm also licenses its brands to third parties and distributes its merchandise through department stores and other wholesale accounts. PVH traces its history to 1881 and is based in New York City.